About the Task Force
Procedure Manual—New!
Methods used by the Task Force to develop reviews and recommendations
Grade Definitions—Updated
Strength of Recommendations and Quality of Evidence
How to Use I Statements in Clinical Practice—New!
Videos on applying I statements
USPSTF Fact Sheet
Questions and Answers
Resource Links
Top of Page
Methods and Processes
Tip: For information on accessing PDF Files, read PDF
Help.
USPSTF Recommendations for STI Screening (PDF File, 185 KB)—New!
Update on Methods: Estimating Certainty and Magnitude of Net Benefit (PDF File, 90 KB)
Current Processes: Refining Evidence-based Recommendation Development (PDF File, 100 KB)
How To Read the New Recommendation Statement: Update (PDF File, 300 KB)
Top of Page
Commentary from the USPSTF
Tip: For information on accessing PDF Files, read PDF
Help.
Expanding Newborn Screening: Process, Policy, and Priorities (PDF File, 190 KB)—New!
Integrating Evidence-Based Clinical and Community Strategies to Improve Health (PDF File, 180 KB)
Top of Page
Background
Tip: For information on accessing PDF Files, read PDF
Help.
Preface (PDF
file, 58 KB)
Introducing
the 3rd USPSTF (PDF
file, 52 KB)
AHRQ
and the USPSTF (PDF
file, 49 KB)
Evolving
Role (PDF File, 97 KB)
Shared Decisionmaking About Screening and Chemoprevention (PDF File, 105 KB)
Top of Page
Methods
Tip: For information on accessing PDF Files, read PDF
Help.
Behavioral
Counseling Interventions (PDF
file, 176 KB)
Current Methods (PDF
file, 122 KB)
Cost-Effectiveness (PDF
file, 95 KB)
Meaning of the Task Force "I" Recommendation: Screening for Hepatitis C
Screening for Type 2 Diabetes: A Cost-effectiveness Analysis (PDF File, 800 KB)
Top of Page
Internet Citation:
Methods and Background. U.S. Preventive
Services Task Force. Agency for Healthcare Research and Quality, Rockville,
MD. http://www.ahrq.gov/clinic/uspstmeth.htm